Invention and commercialization in optical bioimaging

Nature Biotechnology

Volumn 21, Issue 11, 2003, Pages 1269-1271

  Farkas, Daniel L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY REACTION; CLINICAL PRACTICE; COMMERCIAL PHENOMENA; IMAGING SYSTEM; LIGHT; MICROSCOPY; NOTE; OPTICS; POSITRON; PRIORITY JOURNAL;

BIOTECHNOLOGY; COMMERCE; DEVICE APPROVAL; DIAGNOSTIC IMAGING; DIFFUSION OF INNOVATION; INDUSTRY; INTERNATIONALITY; MICROSCOPY; OPTICS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0242290937     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt1103-1269     Document Type: Note

References (11)

1. Bacon, F. Novum Organum (published 1620) (eds. Urbach, P. & Gibson, J.) (Open Court, Chicago, 1993).
2. Ishijima, A. & Yanagida, T. Trends Biochem. Sci. 26, 438-444 (2001).
3. Reits, E.A. & Neefjes, J.J. Nat. Cell. Biol. 3, E145-E147 (2001).
4. Braeckmans, K., Peeters, L., Sanders, N.N., De Smedt, S.C. & Demeester, J. Biophys J. 85, 2240-2252 (2003).
5. Callaway, E.M. & Yuste, R. Curr. Opin. Neurobiol. 12, 587-592 (2002).
6. Greulich, K.O. in Micromanipulation by Light in Biology and Medicine: The Laser Microbeam and Optical Tweezers, Enabling Techniques in Bioimaging (ed. Farkas, D.L.) (Birkhäuser Publishing Company, Basel, 1999).
7. Kuo, S.C. Traffic 2, 757-763 (2001).
8. Carl Zeiss Jena GmbH and Carl Zeiss Inc. v. Bio-Rad Laboratories, Inc. and Cornell Research Foundation, Inc., US District Court, Southern District of New York (CV-98-8012 RCC).
9. Appel, N.M. Ann. NY Acad. Sci. 820, 14-28 (1997).
10. Taylor, D.L. et al. Toxicol. Pathol. 22, 145-159 (1994).
11. Farkas, D.L. in Methods in Cellular Imaging (ed. Periasamy, A.) 345-361 (Oxford University Press, 2001).